Market Size in 2020 | Market Forecast in 2028 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 5.1 billion | USD 13.1 billion | CAGR at 8.7% | 2020 |
worth approximately 5.1(USD Billion) in 2020 and is predicted to gain revenue of about 13.1(USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028. The report offers an assessment and analysis of the Medical Device Regulatory Affairs Market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
The medical device sector plays a core role in the healthcare ecosystem by offering new solutions to enhance patient outcomes. Every firm needs to innovate by using iterative upgradation to current technology or developing new equipment that will provide proficient treatment for a particular ailment. With product developers trying to bring new ideas or solutions to reality, the regulatory affairs service providers play a key part by guiding the team on particular legislations for ensuring that the medical device can be marketed legally. Moreover, regulatory affairs solution providers also advise the product team as to how varied kinds of decisions impact the kind of regulatory submissions along with their deadlines.
Moreover, for products that are distributed globally, regulatory affairs coordinate with regional teams and ensure that the product possesses a global regulatory strategy. For maintaining the effectiveness of the medical device, it is necessary for regulatory affair professional for understanding the global regulatory needs of medical equipment along with assuring that the product development team takes into consideration the global needs of the product post testing & validation.
Escalating demand for fast approval methods, shifting regulations, and swiftly expanding domains like diagnostics & therapeutics will steer the growth of the medical device regulatory affairs market in the years ahead. Apart from this, favorable government schemes and the growing complexity of medical equipment will embellish business space over the years to come. Growing cybersecurity threats and the fiscal impact of data violations on the sale of medical devices are making medical device producers accept strategies to safeguard their products, thereby driving market trends. Furthermore, the occurrence of various kinds of chronic disorders like heart ailments, diabetes, cancer, and respiratory issues will open new vistas of growth for the medical device regulatory affairs industry over the forthcoming years.
In addition to this, AI and machine learning tools help in extracting large amounts of data at the time of delivering healthcare services. With the massive demand for personal protective equipment kits and ventilators due to the large spread of the COVID-19 pandemic, the market for medical device regulatory affairs is anticipated to gain traction in the years ahead.
The Asia Pacific To Make Notable Contributions Towards Overall Market Size By 2028
The expansion of the medical device regulatory affairs market in the Asia Pacific over the forecast timespan is due to massively evolved regulatory tools in countries such as Japan and Australia. Furthermore, supportive government policies for increasing FDAs and the need for increasing approval of new products will steer regional market growth. In addition to this, the necessity of relaxing laws related to procurement control will drive regional industry trends.
Report Attributes | Report Details |
---|---|
Report Name | Medical Device Regulatory Affairs Market Research Report |
Market Size in 2020 | USD 5.1 billion |
Market Forecast in 2028 | USD 13.1 billion |
Growth Rate | CAGR of 8.7% |
Number of Pages | 130 |
Key Companies Covered | Integer Holdings, ICON Plc, Medpace, Emergo, IQVIA Holdings, Intertek Plc, Covance, Promedica International, Freyr, and SGS SA. |
Segments Covered | By Service, By Type, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2020 |
Historical Year | 2018 to 2020 |
Forecast Year | 2021 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Key players profiled in the study include:
The global Medical Device Regulatory Affairs Market is segmented as follows:
FrequentlyAsked Questions
Escalating demand for fast approval method, shifting regulations, and swiftly expanding domains like diagnostics & therapeutics will steer growth of medical device regulatory affairs market in the years ahead. Apart from this, favorable government schemes and growing complexity of medical equipment will embellish business space over the years to come. Growing cybersecurity threats and fiscal impact of data violations on sale of medical devices are making medical device producers accept strategies to safeguard their products, thereby driving market trends. Furthermore, occurrence of various kinds of chronic disorders like heart ailments, diabetes, cancer, and respiratory issues will open new vistas of growth for medical device regulatory affairs industry over the forthcoming years.
In addition to this, AI and machine learning tools help in extracting large amount of data at time of delivering healthcare services. With massive demand for personal protective equipment kits and ventilators due to large spread of COVID 19 pandemic, market for medical device regulatory affairs is anticipated to gain traction in the years ahead.
According to Zion market research report, the global Medical Device Regulatory Affairs market accrued earnings worth approximately 5.1(USD Billion) in 2020 and is predicted to gain revenue of about 13.1(USD Billion) by 2028, is set to record a CAGR of nearly 8.7% over the period from 2021 to 2028.
Asia Pacific will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to massively evolved regulatory tools in countries such as Japan and Australia. Furthermore, supportive government policies for increasing FDAs and need for increasing approval of new products will steer regional market growth. In addition to this, necessity of relaxing laws related to procurement control will drive regional industry trends.
The key market participants include Integer Holdings, ICON Plc, Medpace, Emergo, IQVIA Holdings, Intertek Plc, Covance, Promedica International, Freyr, and SGS SA.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed